CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-05 | McCarthy Sean A. President and CEO | Sale | −4,497 | $25.06 | $113K | 82,063 |
| 2018-07-05 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −4,497 | 155,649 | ||
| 2018-07-03 | McCarthy Sean A. President and CEO | Option exercise | +2,028 | $1.57 | $3K | 84,091 |
| 2018-07-03 | McCarthy Sean A. President and CEO | Sale | −2,028 | $25.09 | $51K | 82,063 |
| 2018-07-03 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −2,028 | 160,146 | ||
| 2018-07-02 | RAY DEBANJAN Chief Financial Officer | Option exercise | +3,000 | $1.26 | $4K | 8,928 |
| 2018-07-02 | RAY DEBANJAN Chief Financial Officer | Sale | −3,000 | $22.56 | $68K | 5,928 |
| 2018-07-02 | RAY DEBANJAN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −3,000 | 2,710 | ||
| 2018-07-02 | McCarthy Sean A. President and CEO | Option exercise | +13,052 | $1.57 | $21K | 95,115 |
| 2018-07-02 | McCarthy Sean A. President and CEO | Sale | −13,052 | $23.42 | $306K | 82,063 |
| 2018-07-02 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −13,052 | 162,174 | ||
| 2018-06-13 | Fuchs Charles S. Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2018-06-13 | Huh Hoyoung Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2018-06-13 | Young Matthew P. Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2018-06-13 | GLUCK FREDERICK W Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2018-06-13 | SCARLETT JOHN A Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2018-06-01 | RAY DEBANJAN Chief Financial Officer | Option exercise | +3,000 | $1.26 | $4K | 8,928 |
| 2018-06-01 | RAY DEBANJAN Chief Financial Officer | Sale | −3,000 | $25.93 | $78K | 5,928 |
| 2018-06-01 | RAY DEBANJAN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −3,000 | 5,710 | ||
| 2018-05-31 | RAY DEBANJAN Chief Financial Officer | Grant or award | +1,187 | $17.90 | $21K | 5,928 |
Page 18 of 33 · 649 trades